Ticker
FENCCompany Name
FENNEC PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -11.68M | -35.08% | $ 33.3M |
3/31/2025 | $ -16.39M | -53.01% | $ 30.91M |
12/31/2024 | $ 26.98M | 56.75% | $ 47.54M |
9/30/2024 | $ 23.59M | 47.81% | $ 49.35M |
6/30/2024 | $ 23.04M | 47.13% | $ 48.89M |
3/31/2024 | $ 27.48M | 61.13% | $ 44.95M |
12/31/2023 | $ -17.14M | -80.67% | $ 21.25M |
9/30/2023 | $ -19.09M | -146.22% | $ 13.05M |
6/30/2023 | $ -21.34M | -326.37% | $ 6.54M |
3/31/2023 | $ -20.78M | -646.92% | $ 3.21M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for FENNEC PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -13.9M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Jun 30, 2021
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |